Cleared Traditional

K101228 - MIRADA XD

K101228 is an FDA 510(k) clearance for MIRADA XD, manufactured by Mirada Medical, Ltd.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 51-day FDA review.

K101228 · Mirada Medical, Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2010
Decision
51d
Days
Class 2
Risk

K101228 is an FDA 510(k) clearance for the MIRADA XD. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Mirada Medical, Ltd. (Oxford, Oxfordshire, GB). The FDA issued a Cleared decision on June 23, 2010 after a review of 51 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Mirada Medical, Ltd. devices

FDA 510(k) Submission Details - K101228

510(k) Number K101228 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 03, 2010
Decision Date June 23, 2010
Days to Decision 51 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
56d faster than avg
Panel avg: 107d · This submission: 51d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1204
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K101228.
SYNGO. PLAZA VA20A
K101666 · Siemens AG Medical Solutions · Aug 2010
SYNAPSE 3D BASIC TOOLS
K101662 · Fujifilm Medical System U.S.A., Inc. · Jul 2010
CORONIS FUSION 10MP, MODEL MDCG-10130
K093197 · Barco N.V. · Jun 2010
SYMBIA.NET, SYMBIA.NET SELECT MODEL 10520828, 10520827
K100619 · Siemens Medical Solutions USA, Inc. · May 2010
CAAS QVA 3D, CAAS QCA 3D
K100292 · Pie Medical Imaging BV · Apr 2010
SYNAPSE OBLIQUUS MIP/MPR/FUSION
K100881 · Fujifilm Medical System U.S.A., Inc. · Apr 2010